Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children

NCT02541760 is registered in ClinicalTrials.gov with Hormozgan University of Medical Sciences as lead sponsor.

NCT NCT02541760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02541760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monteleukast Versus Inhaled Mometasone for Treatment of Otitis Media With Effusion in Children
Lead sponsor
Hormozgan University of Medical Sciences
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2014
Completion date
April 30, 2015
Enrollment
143 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

otitis media with effiusion